Mesoblast Ltd - ADR

NASDAQ:MESO  
10.68
-0.18 (-1.66%)
4:15:51 PM EDT: $10.98 +0.30 (+2.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.34B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$15.58 Million
Adjusted EPS-$0.40
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Mesoblast Ltd - ADR Stock, NASDAQ:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Australia
Phone: +61.3.9639.6036
Number of Employees: 73

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.